Pharmaceuticals in Mexico

Pharmaceuticals in Mexico


  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Mexico

Summary

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Mexico pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Mexican pharmaceuticals market had total revenues of USD 20.3bn in 2017, representing a compound annual growth rate (CAGR) of 5.8% between 2013 and 2017.

- In line with many developing nations, Mexico has been experiencing an epidemiological transition from communicable diseases to chronic degenerative diseases. It is these factors which are generating growth.

- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products in Mexico.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Mexico

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Mexico pharmaceuticals market by value in 2017?

- What will be the size of the Mexico pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Mexico pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Mexico's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 19

Threat of substitutes 21

Degree of rivalry 22

Leading Companies 24

Bayer AG 24

Merck & Co., Inc. 28

Novartis AG 31

Pfizer Inc. 34

Macroeconomic Indicators 38

Country data 38

Methodology 40

Industry associations 41

Related MarketLine research 41

Appendix 42

About MarketLine 42

List of Figures

Figure 1: Mexico pharmaceuticals market value: USD billion, 2013-17

Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Mexico pharmaceuticals market share: % share, by value, 2017

Figure 4: Mexico pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Mexico, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Mexico, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Mexico, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2017

Figure 11: Bayer AG: revenues & profitability

Figure 12: Bayer AG: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

List of Tables

Table 1: Mexico pharmaceuticals market value: USD billion, 2013-17

Table 2: Mexico pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Mexico pharmaceuticals market share: % share, by value, 2017

Table 4: Mexico pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Bayer AG: key facts

Table 6: Bayer AG: key financials (USD )

Table 7: Bayer AG: key financials (EUR)

Table 8: Bayer AG: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: Novartis AG: key facts

Table 13: Novartis AG: key financials (USD )

Table 14: Novartis AG: key financial ratios

Table 15: Pfizer Inc.: key facts

Table 16: Pfizer Inc.: key financials (USD )

Table 17: Pfizer Inc.: key financial ratios

Table 18: Mexico size of population (million), 2013-17

Table 19: Mexico gdp (constant 2005 prices, USD billion), 2013-17

Table 20: Mexico gdp (current prices, USD billion), 2013-17

Table 21: Mexico inflation, 2013-17

Table 22: Mexico consumer price index (absolute), 2013-17

Table 23: Mexico exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25344
Site License
USD 700 INR 50687
Corporate User License
USD 1050 INR 76031

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com